Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants

Abstract The most frequent biochemical defect of inherited mitochondrial disease is isolated complex I deficiency. There is no cure for this disorder, and treatment is mainly supportive. In this study, we investigated the effects of human mesenchymal stem cells (MSCs) on skin fibroblast derived from...

Full description

Bibliographic Details
Main Authors: Tharsini Navaratnarajah, Marlen Bellmann, Annette Seibt, Ruchika Anand, Özer Degistirici, Roland Meisel, Ertan Mayatepek, Andreas Reichert, Fabian Baertling, Felix Distelmaier
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-022-02932-x
_version_ 1818555430775816192
author Tharsini Navaratnarajah
Marlen Bellmann
Annette Seibt
Ruchika Anand
Özer Degistirici
Roland Meisel
Ertan Mayatepek
Andreas Reichert
Fabian Baertling
Felix Distelmaier
author_facet Tharsini Navaratnarajah
Marlen Bellmann
Annette Seibt
Ruchika Anand
Özer Degistirici
Roland Meisel
Ertan Mayatepek
Andreas Reichert
Fabian Baertling
Felix Distelmaier
author_sort Tharsini Navaratnarajah
collection DOAJ
description Abstract The most frequent biochemical defect of inherited mitochondrial disease is isolated complex I deficiency. There is no cure for this disorder, and treatment is mainly supportive. In this study, we investigated the effects of human mesenchymal stem cells (MSCs) on skin fibroblast derived from three individuals with complex I deficiency carrying different pathogenic variants in mitochondrial DNA-encoded subunits (MT-ND3, MT-ND6). Complex I-deficient fibroblasts were transiently co-cultured with bone marrow-derived MSCs. Mitochondrial transfer was analysed by fluorescence labelling and validated by Sanger sequencing. Levels of reactive oxygen species (ROS) were measured using MitoSOX Red. Moreover, mitochondrial respiration was analysed by Seahorse XFe96 Extracellular Flux Analyzer. Levels of antioxidant proteins were investigated via immunoblotting. Co-culturing of complex I-deficient fibroblast with MSCs lowered cellular ROS levels. The effect on ROS production was more sustained compared to treatment of patient fibroblasts with culture medium derived from MSC cultures. Investigation of cellular antioxidant defence systems revealed an upregulation of SOD2 (superoxide dismutase 2, mitochondrial) and HO-1 (heme oxygenase 1) in patient-derived cell lines. This adaptive response was normalised upon MSC treatment. Moreover, Seahorse experiments revealed a significant improvement of mitochondrial respiration, indicating a mitigation of the oxidative phosphorylation defect. Experiments with repetitive MSC co-culture at two consecutive time points enhanced this effect. Our study indicates that MSC-based treatment approaches might constitute an interesting option for patients with mitochondrial DNA-encoded mitochondrial diseases. We suggest that this strategy may prove more promising for defects caused by mitochondrial DNA variants compared to nuclear-encoded defects.
first_indexed 2024-12-12T09:53:22Z
format Article
id doaj.art-c56be867ce0047c3ab3933fd392a5a64
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-12T09:53:22Z
publishDate 2022-06-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-c56be867ce0047c3ab3933fd392a5a642022-12-22T00:28:13ZengBMCStem Cell Research & Therapy1757-65122022-06-0113111010.1186/s13287-022-02932-xMesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variantsTharsini Navaratnarajah0Marlen Bellmann1Annette Seibt2Ruchika Anand3Özer Degistirici4Roland Meisel5Ertan Mayatepek6Andreas Reichert7Fabian Baertling8Felix Distelmaier9Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Medical Faculty, Heinrich Heine University DüsseldorfDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Medical Faculty, Heinrich Heine University DüsseldorfDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Medical Faculty, Heinrich Heine University DüsseldorfInstitute of Biochemistry and Molecular Biology I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfDivision of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University DüsseldorfDivision of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University DüsseldorfDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Medical Faculty, Heinrich Heine University DüsseldorfInstitute of Biochemistry and Molecular Biology I, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University DüsseldorfDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Medical Faculty, Heinrich Heine University DüsseldorfDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Medical Faculty, Heinrich Heine University DüsseldorfAbstract The most frequent biochemical defect of inherited mitochondrial disease is isolated complex I deficiency. There is no cure for this disorder, and treatment is mainly supportive. In this study, we investigated the effects of human mesenchymal stem cells (MSCs) on skin fibroblast derived from three individuals with complex I deficiency carrying different pathogenic variants in mitochondrial DNA-encoded subunits (MT-ND3, MT-ND6). Complex I-deficient fibroblasts were transiently co-cultured with bone marrow-derived MSCs. Mitochondrial transfer was analysed by fluorescence labelling and validated by Sanger sequencing. Levels of reactive oxygen species (ROS) were measured using MitoSOX Red. Moreover, mitochondrial respiration was analysed by Seahorse XFe96 Extracellular Flux Analyzer. Levels of antioxidant proteins were investigated via immunoblotting. Co-culturing of complex I-deficient fibroblast with MSCs lowered cellular ROS levels. The effect on ROS production was more sustained compared to treatment of patient fibroblasts with culture medium derived from MSC cultures. Investigation of cellular antioxidant defence systems revealed an upregulation of SOD2 (superoxide dismutase 2, mitochondrial) and HO-1 (heme oxygenase 1) in patient-derived cell lines. This adaptive response was normalised upon MSC treatment. Moreover, Seahorse experiments revealed a significant improvement of mitochondrial respiration, indicating a mitigation of the oxidative phosphorylation defect. Experiments with repetitive MSC co-culture at two consecutive time points enhanced this effect. Our study indicates that MSC-based treatment approaches might constitute an interesting option for patients with mitochondrial DNA-encoded mitochondrial diseases. We suggest that this strategy may prove more promising for defects caused by mitochondrial DNA variants compared to nuclear-encoded defects.https://doi.org/10.1186/s13287-022-02932-xMitochondrial DNAMesenchymal stem cellsComplex IGene therapyMitochondrial transferND3
spellingShingle Tharsini Navaratnarajah
Marlen Bellmann
Annette Seibt
Ruchika Anand
Özer Degistirici
Roland Meisel
Ertan Mayatepek
Andreas Reichert
Fabian Baertling
Felix Distelmaier
Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants
Stem Cell Research & Therapy
Mitochondrial DNA
Mesenchymal stem cells
Complex I
Gene therapy
Mitochondrial transfer
ND3
title Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants
title_full Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants
title_fullStr Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants
title_full_unstemmed Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants
title_short Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants
title_sort mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic mt nd3 and mt nd6 variants
topic Mitochondrial DNA
Mesenchymal stem cells
Complex I
Gene therapy
Mitochondrial transfer
ND3
url https://doi.org/10.1186/s13287-022-02932-x
work_keys_str_mv AT tharsininavaratnarajah mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT marlenbellmann mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT annetteseibt mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT ruchikaanand mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT ozerdegistirici mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT rolandmeisel mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT ertanmayatepek mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT andreasreichert mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT fabianbaertling mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants
AT felixdistelmaier mesenchymalstemcellsimproveredoxhomeostasisandmitochondrialrespirationinfibroblastcelllineswithpathogenicmtnd3andmtnd6variants